Reversal of medetomidine-induced sedation in reindeer (Rangifer tarandus tarandus) with atipamezole increases the medetomidine concentration in plasma

Journal of Veterinary Pharmacology and Therapeutics

Volumn 20, Issue 5, 1997, Pages 350-354

  Ranheim, B ^a   Horsberg, T E ^a   Nymoen, U ^a   Soli N E ^a   Tyler, N J C ^b   Arnemo, J M ^a  

^a NORWEGIAN UNIVERSITY OF LIFE SCIENCES   (Norway)

^b UNIVERSITY OF TROMSØ   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ATIPAMEZOLE; MEDETOMIDINE; UNCLASSIFIED DRUG; ZALOPINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; CONTROLLED STUDY; DEER; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; SEDATION;

ANIMALIA; CERVIDAE; MAMMALIA; RANGIFER; RANGIFER TARANDUS; RANGIFER TARANDUS TARANDUS;

EID: 0030763860     PISSN: 01407783     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2885.1997.00080.x     Document Type: Article

References (19)

1. Bøe, U.L. & Jacobsen, E. (1981) Trials with different feeds to reindeer. Rangifer, 1, 39-43.
2. Dyer, D.C., Hsu, W.H. & Lloyd, W.E. (1987) Pharmacokinetics of xylazine in ponies: influence of yohimbine. Archives Internationales de Pharmacodynamie et de Therapie, 289, 5-10.
3. Garner, D.L. & Addison, E.M. (1994) Postpartum Immobilization of Adult Female Moose using Xylazine, Ketamine and Yohimbine Hydrochlorides. Journal of Wildlife Diseases, 30, 123-125.
4. Jalanka, H. (1989) The use of medetomidine, medetomidine-ketamine combinations and atipamezole at Helsinki Zoo - a review of 240 cases. Acta Veterinaria Scandinavica, 85, 195-197.
5. 2-agonists and antagonists. In Zoo and Wild Animal Medicine: Current Therapy 3. Ed. Fowler, M. E. pp. 477-481. W. B. Saunders Company, Philadelphia.
6. Jalanka, H. & Roeken, B.O. (1990) The use of medetomidine, medetomidine-ketamine combinations, and atipamezole in nondomestic mammals: a review. Journal of Zoo and Wildlife Medicine, 21, 259-282.
7. Ko, J.C.H., Thurmon, J.C., Benson, G.J., Tranquilli, W.J., Olson, W.A. & Vähä-Vahe, T. (1994) Hemodynamic and anesthetic effects of etomidate in medetomidine-premedicated dogs. American Journal of Veterinary Reusearch, 6, 842-846.
8. Muge, D.K., Chambers, J.P. & Livingston, A. (1996) Single dose pharmacokinetics of medetomidine in sheep. Journal of Veterinary Pharmacology and Therapeutics, 19, 109-112.
9. Nilssen, K.J., Sundsfjord, J.A. & Blix, A.S. (1984) Regulation of metabolic rate in Svalbard and Norwegian reindeer. American Journal of Physiology, 247, R837-R841.
10. Regelin, W.L., Schwartz, C.C. & Franzmann, A.W. (1985) Seasonal energy metabolism of adult moose. The Journal of Wildlife Management, 49, 388-393.
11. Salonen, J.S. & Eloranta, M. (1990) Biotransformation of medetomidine in the rat. Xenobiotica, 20, 471-480.
12. Salonen, J.S. (1989) Pharmacokinetics of medetomidine. Acta Veterinaria Scandinavica, 85, 49-54.
13. 2-adrenoceptor agonists. In Animal Pain. Eds Short, C. E. & Van Poznak, A. pp. 191-200. Churchill Livingstone Inc., New York.
14. Salonen, J.S., Vuorilehto, L., Vainio, O. & Antilla, M. (1995) Atipamezole increases medetomidine clearance in the dog: an agonist-antagonist interaction. Journal of Veterinary Pharmacology and Therapeutics, 18, 528-352.
15. 2-adrenoceptors. Journal of Autonomie Pharmacology, 5, 275-284.
16. Tyler, N.J.C., Hotvedt, R., Blix, A.S. & Sorensen, D.R. (1990a) Immobilization of Norwegian Reindeer (Rangifer tarandus tarandus) and Svalhard Reindeer (Rangifer tarandus platyrhynchus) with medetomidine and medetomidine-ketamine and reversal with atipamezole. Acta Veterinaria Scandinavica, 31, 479-488.
17. Tyler, N.J.C., Jalanka, H., Holvedt, R., Blix, A.S. & Sorensen, D.R. (1990b) Immobilization of three sub-species of reindeer (Rangifer tarandus) with medetomidine and medetomidine-ketamine and reversal with atipamezole. Rangifer, 4 (special issue), 65-66.
18. 2-adrenoceptor agonist. European Journal of Pharmacology, 150, 9-14.
19. 2-adrenoceptors by atipamezole. Archives Internationales de Pharmacodynamie et de Therapie, 297, 190-204.